Zobrazeno 1 - 10
of 293
pro vyhledávání: '"van Klingeren B"'
Publikováno v:
Journal of Applied Ecology, 1966 Jun 01. 3, 125-131.
Externí odkaz:
https://www.jstor.org/stable/2401451
Autor:
Nair, Parukutty, Henderson, John, Frenay, H. M. E., Schot, C. S., Van Leeuwen, W. J., Rost, J. A., De Neeling, A. J., Van Klingeren, B., Verhoef, J., Goodall, B., Tompkins, D. S., Duckworth, G.
Publikováno v:
BMJ: British Medical Journal, 1994 Jan 01. 308(6920), 57-59.
Externí odkaz:
https://www.jstor.org/stable/29722129
Autor:
de Jong, J. C., van Klingeren, B.
Publikováno v:
BMJ: British Medical Journal, 1989 Jun . 298(6688), 1646-1647.
Externí odkaz:
https://www.jstor.org/stable/29704408
Autor:
Havelaar AH, van Klingeren B
In het afvalwater van een viertal ziekenhuizen werd Pseudomonas aeruginosa aangetroffen in aantallen varierend van 3,2x10-2 tot 6,6x10-4 cfu/ml. Dit was aanzienlijk hoger dan in huishoudelijk afvalwater (< 10-1-1,9x10-2 cfu/ml). Isolaten uit ziekenhu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::b784eb91d0ea7d8849be2befa3a3b57c
http://hdl.handle.net/10029/258933
http://hdl.handle.net/10029/258933
Autor:
Helen Giamarellou, van Klingeren B, Verbist L, Mittermayer H, M. Kresken, Silvano Esposito, Fritz H. Kayser, Reeves Ds, Hafner D, Bergogne-Bérézin E
Publikováno v:
Infection. 22:S90-S98
Since 1984, when the first fluoroquinolone, norfloxacin, was marketed in Europe, there has been a marked increase in the usage of this class of drugs. In order to evaluate the influence of this drug usage on the prevalence of resistance to fluoroquin
Autor:
Lambregts-van Weezenbeek, C. S., Jansen, H. M., Nagelkerke, N. J., van Klingeren, B., Veen, J.
Publikováno v:
international journal of tuberculosis and lung disease, 2(4), 288-295. International Union Against Tuberculosis and Lung Disease (The Union)
The Netherlands, 1993 and 1994. To determine 1) rates of drug resistance in relation to nationality and country of birth, 2) risk factors for drug resistance, 3) treatment outcome of drug-resistant cases, and 4) rates of primary and acquired drug res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::2459580aff6eaa44d0621a7c54129c36
https://pure.amc.nl/en/publications/nationwide-surveillance-of-drugresistant-tuberculosis-in-the-netherlands-rates-risk-factors-and-treatment-outcome(5f14a060-09e7-4709-b619-97d7bd967a07).html
https://pure.amc.nl/en/publications/nationwide-surveillance-of-drugresistant-tuberculosis-in-the-netherlands-rates-risk-factors-and-treatment-outcome(5f14a060-09e7-4709-b619-97d7bd967a07).html
Autor:
Hermans, PWM, Sluijter, Marcel, Elzenaar, K, van t Veen, A, Schonkeren, JJM, Nooren, FM, Leeuwen, Wibeke, de Neeling, AJ, van Klingeren, B, Verbrugh, Henri, Garhasbi, M
Publikováno v:
Journal of Infectious Diseases, 1413-1422. Oxford University Press
ISSUE=175;STARTPAGE=1413;ENDPAGE=1422;ISSN=0022-1899;TITLE=Journal of Infectious Diseases
ISSUE=175;STARTPAGE=1413;ENDPAGE=1422;ISSN=0022-1899;TITLE=Journal of Infectious Diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::9115826215ef29b0d6ecef37b7c3bb3d
https://pure.eur.nl/en/publications/5c5c715d-9385-44db-a148-1af5adf13a8f
https://pure.eur.nl/en/publications/5c5c715d-9385-44db-a148-1af5adf13a8f
Autor:
van Duynhoven YT, van Klingeren B, van Santen-Verheuvel MG, van der Meijden WI, van de Laar MJ, van Duynhoven, Y T, van Klingeren, B, van Santen-Verheuvel, M G, van der Meijden, W I, van de Laar, M J
Publikováno v:
Sexually Transmitted Diseases; Aug97, Vol. 24 Issue 7, p409-417, 9p
Autor:
Gascoyne, Deborah M., Heritage, John, Hawkey, Peter M., Turner, Andrew, van Klingeren, Bert, Gascoyne, D M, Heritage, J, Hawkey, P M, Turner, A, van Klingeren, B
Publikováno v:
Journal of Antimicrobial Chemotherapy (JAC); Aug1991, Vol. 28 Issue 2, p173-183, 11p